RecruitingNCT03511586
Total Shoulder Arthroplasty Multi-Center Registry
Sponsor
Arthrex, Inc.
Enrollment
2,500 participants
Start Date
Jul 28, 2015
Study Type
OBSERVATIONAL
Conditions
Summary
The objective of the study is a multi-center prospective registry to collect clinical outcomes of anatomic and reverse total shoulder arthroplasty.
Eligibility
Min Age: 18 YearsMax Age: 100 Years
Inclusion Criteria4
- Patient voluntarily consents to participate in the study and has the mental and physical ability to participate in the study, fill out subjective questionnaires, return for follow-up visits, and comply with prescribed post-operative physical therapy.
- Patient is between the ages of 18 and 100 years.
- The patient has a planned primary or revision implantation of an anatomic (hemi-arthroplasty or total arthroplasty) or a reverse shoulder prosthesis system manufactured by Arthrex.
- Patient has a standard of care preoperative CT taken within 6 months that has been submitted for Arthrex VIP (Virtual Implant Positioning) planning.
Exclusion Criteria1
- \. Patient has known intentions, obligations, or co-morbidity that would inhibit them from participating in the study.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(24)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03511586
Related Trials
Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total Shoulder Arthroplasty
NCT069027141 location
Hospital for Special Surgery Shoulder Arthroplasty Cohort
NCT005278392 locations
Shoulder Innovations Clinical Data Registry
NCT067541506 locations
Role of Nutritional Status in Functional Recovery of Older Adults Undergoing Virtual Reality-augmented Shoulder Rehabilitation (VIR)
NCT072825611 location
Post-incision Antimicrobial Wash vs C. Acnes in Shoulder Arthroplasty
NCT068314221 location